These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 22124156)
1. A deacetylase-deficient SIRT1 variant opposes full-length SIRT1 in regulating tumor suppressor p53 and governs expression of cancer-related genes. Shah ZH; Ahmed SU; Ford JR; Allison SJ; Knight JR; Milner J Mol Cell Biol; 2012 Feb; 32(3):704-16. PubMed ID: 22124156 [TBL] [Abstract][Full Text] [Related]
2. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming. Ong ALC; Ramasamy TS Ageing Res Rev; 2018 May; 43():64-80. PubMed ID: 29476819 [TBL] [Abstract][Full Text] [Related]
3. Function of the SIRT1 protein deacetylase in cancer. Stünkel W; Peh BK; Tan YC; Nayagam VM; Wang X; Salto-Tellez M; Ni B; Entzeroth M; Wood J Biotechnol J; 2007 Nov; 2(11):1360-8. PubMed ID: 17806102 [TBL] [Abstract][Full Text] [Related]
4. Negative regulation of the deacetylase SIRT1 by DBC1. Zhao W; Kruse JP; Tang Y; Jung SY; Qin J; Gu W Nature; 2008 Jan; 451(7178):587-90. PubMed ID: 18235502 [TBL] [Abstract][Full Text] [Related]
5. SIRT1 knockdown up-regulates p53 and p21/Cip1 expression in renal adenocarcinoma cells but not in normal renal-derived cells in a deacetylase-independent manner. Fujino T; Yokokawa R; Oshima T; Hayakawa M J Toxicol Sci; 2018; 43(12):711-715. PubMed ID: 30518708 [TBL] [Abstract][Full Text] [Related]
6. SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53. Lynch CJ; Shah ZH; Allison SJ; Ahmed SU; Ford J; Warnock LJ; Li H; Serrano M; Milner J PLoS One; 2010 Oct; 5(10):e13502. PubMed ID: 20975832 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer. Kiga K; Fukuda-Yuzawa Y; Tanabe M; Tsuji S; Sasakawa C; Fukao T RNA Biol; 2014; 11(11):1347-54. PubMed ID: 25483038 [TBL] [Abstract][Full Text] [Related]
9. Serum withdrawal up-regulates human SIRT1 gene expression in a p53-dependent manner. Shang L; Zhou H; Xia Y; Wang H; Gao G; Chen B; Liu Q; Shao C; Gong Y J Cell Mol Med; 2009 Oct; 13(10):4176-84. PubMed ID: 19267881 [TBL] [Abstract][Full Text] [Related]
10. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes. Herbert KJ; Cook AL; Snow ET Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431 [TBL] [Abstract][Full Text] [Related]
11. USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. Lin Z; Yang H; Kong Q; Li J; Lee SM; Gao B; Dong H; Wei J; Song J; Zhang DD; Fang D Mol Cell; 2012 May; 46(4):484-94. PubMed ID: 22542455 [TBL] [Abstract][Full Text] [Related]
12. Sirtuin1-p53: A potential axis for cancer therapy. Yin JY; Lu XT; Hou ML; Cao T; Tian Z Biochem Pharmacol; 2023 Jun; 212():115543. PubMed ID: 37037265 [TBL] [Abstract][Full Text] [Related]
13. CSAG2 is a cancer-specific activator of SIRT1. Yang X; Potts PR EMBO Rep; 2020 Sep; 21(9):e50912. PubMed ID: 32761762 [TBL] [Abstract][Full Text] [Related]
14. TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage. Magni M; Buscemi G; Maita L; Peng L; Chan SY; Montecucco A; Delia D; Zannini L Cell Death Differ; 2019 May; 26(5):918-931. PubMed ID: 30050056 [TBL] [Abstract][Full Text] [Related]
15. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Kim EJ; Kho JH; Kang MR; Um SJ Mol Cell; 2007 Oct; 28(2):277-90. PubMed ID: 17964266 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress-induced inhibition of Sirt1 by caveolin-1 promotes p53-dependent premature senescence and stimulates the secretion of interleukin 6 (IL-6). Volonte D; Zou H; Bartholomew JN; Liu Z; Morel PA; Galbiati F J Biol Chem; 2015 Feb; 290(7):4202-14. PubMed ID: 25512378 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Luan S; Sun L; Huang F Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934 [TBL] [Abstract][Full Text] [Related]
19. A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells. Nelson LE; Valentine RJ; Cacicedo JM; Gauthier MS; Ido Y; Ruderman NB Am J Physiol Cell Physiol; 2012 Jul; 303(1):C4-C13. PubMed ID: 22378745 [TBL] [Abstract][Full Text] [Related]
20. P53 and Sirt1: routes of metabolism and genome stability. Gonfloni S; Iannizzotto V; Maiani E; Bellusci G; Ciccone S; Diederich M Biochem Pharmacol; 2014 Nov; 92(1):149-56. PubMed ID: 25218422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]